D-0229-2022 Class II Terminated
FDA drug recall D-0229-2022 was initiated by Ascend Laboratories LLC on Nov 3, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Dec 21, 2022). Affected quantity: 4104 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 17, 2021
- Initiation Date
- Nov 3, 2021
- Termination Date
- Dec 21, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4104 bottles
Product description
Cefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alken Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054 NDC 67877-584-50
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide
Code information
Lot 20140282, exp Dec 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0229-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026